Skip to main content
OpenTrials

Clinical trial condition

Cytomegalovirus Retinitis

Explore clinical trials studying Cytomegalovirus Retinitis. Study availability and eligibility vary by location and protocol.

59 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Cytomegalovirus Retinitis trial results

Completed

A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

NCT00002257

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • East Bay AIDS Ctr Berkeley, California, United States
  • Davies Med Ctr / c/o HIV Institute San Francisco, California, United States
  • Dr David Busch San Francisco, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details
Completed

A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

NCT00002016

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • Harvard (Massachusetts Gen Hosp) Boston, Massachusetts, United States
  • Univ TX Galveston Med Branch Galveston, Texas, United States
View Trial Details
Completed

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

NCT00002070

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Agranulocytosis, +39 more
Locations
  • USC School of Medicine / Norris Cancer Hosp Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Children's Hosp of San Francisco San Francisco, California, United States
  • Pacific Presbyterian San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

NCT00002156

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • Retina - Vitreous Associates Med Group Los Angeles, California, United States
  • Community Eye Med Group Pasadena, California, United States
  • San Diego Naval Hosp San Diego, California, United States
  • Univ of California San Francisco / SF Gen Hosp San Francisco, California, United States
View all 18 locations
View Trial Details
Completed

A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes

NCT00002355

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +24 more
Locations
  • Retina - Vitreous Associates Med Group Los Angeles, California, United States
  • Community Eye Med Group Pasadena, California, United States
  • Santa Clara Valley Med Ctr San Jose, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

NCT00002356

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations
  • UCI College of Medicine Irvine, California, United States
  • Retina - Vitreous Associates Med Group Los Angeles, California, United States
  • Community Eye Med Group Pasadena, California, United States
  • San Diego Naval Hosp San Diego, California, United States
View all 25 locations
View Trial Details

Related conditions